文献速递免疫规划传染病防控与疫情报告

近期季节性流感疫苗接种对候选大流行甲型H5N1流感疫苗血清抗体应答的影响:一项荟萃分析

Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis.
PubMed 文献 · Vaccine · 2019-05-31

该荟萃分析纳入7项随机对照试验的2015名受试者,采用倾向性评分匹配比较近期接种季节性流感疫苗者与未近期接种者对H5N1疫苗的血清抗体应答。结果显示近期接种者H5N1疫苗血清阳转率显著降低,几何平均滴度也较低。

要点

  • 近期接种季节性流感疫苗者接种H5N1疫苗后血清阳转率显著降低(调整OR 0.76)。
  • 未近期接种者H5N1疫苗血凝抑制抗体几何平均滴度较近期接种者高18%。
  • 需进一步研究明确近期接种者对H5N1疫苗免疫应答降低的机制。

核心结论

  • 近期接种季节性流感疫苗者接种H5N1疫苗后血清阳转率显著低于未近期接种者,且血凝抑制抗体几何平均滴度较低。

研究设计与样本

  • 荟萃分析纳入7项随机对照试验的2015名受试者,其中915名(45%)为近期接种季节性流感疫苗者,采用倾向性评分匹配进行分析。

主要发现

  • 近期接种季节性流感疫苗者接种H5N1疫苗后血清阳转率显著降低(调整OR 0.76;95%CI 0.60-0.96;p=0.024)。
  • 未近期接种者H5N1疫苗血凝抑制抗体几何平均滴度较近期接种者高18%(GM比值1.18;95%CI 1.04-1.33;p=0.008)。

局限性

  • 需进一步研究明确近期接种季节性流感疫苗者接种H5N1疫苗后免疫应答降低的影响与机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent studies have suggested that among those receiving seasonal influenza vaccine (SIV), reduced immunogenicity is observed in recently vaccinated (RV; within the past season or 2) persons when compared with those not recently vaccinated (NRV). We performed a meta-analysis to assess the effect of recent immunization with SIV on serum H5 hemagglutination inhibition (HAI) antibody responses after influenza A/H5N1 vaccination using data from a series of randomized controlled trials. The primary outcome was seroconversion measured by HAI assays following receipt of 2 doses of H5N1 vaccine. The geometric mean titer (GMT) of serum HAI antibody after vaccination was the secondary outcome. Analyses were performed using propensity score (PS) matching. The PS for each individual in the meta-analysis cohort was calculated using logistic regression and covariates included age, gender, race, antigen dose, adjuvant, statin use and vaccine manufacturer. 2015 subjects enrolled in 7 clinical trials were eligible for inclusion in the meta-analysis cohort; among these, 915 (45%) were RV. 901 RV subjects were matched (1:1) with replacement to a subject who was NRV. Subjects who received SIV within the previous season were significantly less likely to seroconvert following H5N1 vaccination (adjusted odds ratio 0.76; 95%CI 0.60-0.96; p = 0.024), and the GMT was 18% higher among NRV subjects (GM ratio of HAI antibody 1.18; 95%CI 1.04-1.33; p = 0.008). Further work is needed to better define the effects of, and mechanisms contributing to, reduced immune responses to H5N1 vaccine among RV subjects.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Keitel WA, Voronca DC, Atmar RL, et al. Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis. Vaccine. 2019. PMID: 31160101. doi:10.1016/j.vaccine.2019.04.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。